Presented at WRIB 2024, this study explores how genetic makeup influences drug response, paving the way for personalized medicine. By comparing buccal swab and blood samples using the Agena MassARRAY® system, we analyze DNA yield, quality, stability, and patient compliance. Our research guides the strategic selection of optimal pharmacogenomic sampling methods.
Download now to enhance your clinical trial strategies with cutting-edge insights!
Authors:
Tom Zhang, PhD
Chief Scientific Officer, Large Molecule Bioanalysis
Thomas Lloyd
Expert Scientist, Automation
Jacob Blacutt
Scientist, Genomics
